Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Revance Therapeutics Company Profile (NASDAQ:RVNC)

Consensus Ratings for Revance Therapeutics (NASDAQ:RVNC) (?)
Ratings Breakdown: 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $26.95 (22.95% upside)

Analysts' Ratings History for Revance Therapeutics (NASDAQ:RVNC)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/9/2015TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
12/11/2014ZacksDowngradeNeutral$18.90ViewTweet This Rating  Share This Rating on StockTwits
12/9/2014William BlairInitiated CoverageOutperform$35.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014BMO Capital MarketsInitiated CoverageOutperform$37.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014Cowen and CompanyInitiated CoverageOutperform$55.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014Piper JaffrayInitiated CoverageOverweight$44.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/26/2013 forward)